18 results on '"Emre Arpali"'
Search Results
2. Influence of Preoperative Pain Duration on Microsurgical Varicocelectomy Outcomes
- Author
-
Mustafa Gökhan Köse, Kadir Önem, Mehmet Çetinkaya, Erkan Karadağ, and Emre Arpali
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Objective. To investigate the question of whether duration of pain before surgery ultimately affects sperm parameters after varicocelectomy. Methods. Fifty patients with painful grade-3 varicocele were investigated prospectively. The patients were divided into two groups according to their symptom period. The patients having had grade-3 varicocele for less than 1 year were included in Group-1 (Ge, n=25). Twenty-five patients who had painful grade-3 varicocele for more than 1 year (Gs, n=25) were classified in Group-2. Semen analysis was performed after 3 days of sexual abstinence twice a month. Total sperm concentration (TSC), rapidly progressive motility (SPa), and slow or sluggish motility (SPb) rates were noted. Pain was evaluated by using 10 cm visual analogue scale (VAS). Results. Postoperative TSC and %SPb were significantly higher in both groups (P=0.01). There was no difference between two groups for preoperative and postoperative TSC, %SPa, % and SPb values. VAS significantly declined in both groups (P=0.005). This postoperative decline was not significant for intergroup comparison. Conclusions. Our results show that increase in semen quality and decrease in the pain after microsurgery varicocelectomy do not depend on the duration of the preoperative pain.
- Published
- 2013
- Full Text
- View/download PDF
3. Our Percutaneous Nephrolithotomy Experience
- Author
-
Bekir Voyvoda, Semih Sargın, Emre Arpali, Mert Altinel, Ahmet Yazıcıoğlu, and Faruk Gönenç
- Subjects
General Medicine - Published
- 2023
4. Hand-assisted laparoscopic donor nephrectomy in kidneys with multiple renal arteries versus a single renal artery: An analysis of vascular complications from 1,350 cases
- Author
-
Burak Kocak, Basak Akyollu, Emre Arpali, Bilal Gunaydin, Cihan Karatas, Doğukan Yaprak, Arpalı, Emre, Karataş, Cihan, Akyollu, Başak, Yaprak, Doğukan, Koçak, Burak, Günaydın, Bilal, and Koç University Hospital
- Subjects
Transplantation ,Kidney ,medicine.medical_specialty ,business.industry ,Medicine ,Urology and nephrology ,medicine.medical_treatment ,Perioperative ,Nephrectomy ,Surgery ,medicine.anatomical_structure ,medicine.artery ,Hand-assisted laparoscopic donor nephrectomy ,Multiple renal arteries ,Vascular complications ,Renal artery ,Risk factor ,business ,Body mass index ,MRAS ,Artery - Abstract
Objective: laparoscopic donor nephrectomy (LDN) has been shown to be a safe approach with better morbidity results. Impact of multiple renal arteries (MRAs) and anatomical variations has been reviewed by many authors. In our study, the relationship between the donors with MRAs and risk of perioperative vascular complications related to donor nephrectomy was investigated. Material and methods: patients who underwent hand-assisted LDNs between January 2007 and February 2018 were reviewed retrospectively. Patient age, sex, body mass index (BMI), waist circumference, side of donor nephrectomies, donors with MRAs, intraoperative vascular complications, conversion rates, hospitalization durations, and operative times were extracted. Risk factors for perioperative vascular complications were defined. Results: there were MRAs in 288 kidney donors (21.3%). The number of patients who underwent a right donor nephrectomy was 113 (8.4%). BMI, waist circumference, and postoperative hospital stay were not significantly different between donors with one artery and those with MRAs (p>0.05). The renovascular complication rate and overall conversion rate to open surgery were significantly higher in donors with MRAs (p, NA
- Published
- 2020
5. Utilization of single-use flexible ureterorenoscope for ex-vivo stone extraction in living kidney donors
- Author
-
Emre Arpali, Murat Can Kiremit, Ersin Koseoglu, and Burak Kocak
- Subjects
single-use ureteroscope ,medicine.medical_specialty ,Kidney ,Single use ,medicine.diagnostic_test ,living donor nephrectomy ,business.industry ,Urology ,urolithiasis ,Video Abstract ,General Medicine ,renal transplantation ,Living donor nephrectomy ,medicine.anatomical_structure ,Stone extraction ,Medicine ,Ureteroscopy ,ureteroscopy ,business ,Ex vivo - Published
- 2022
6. Oligosymptomatic Kidney Transplant Patients With COVID-19: Do They Pose a Risk to Other Recipients?
- Author
-
Burak Kocak, Aydin Turkmen, Mehmet Kanbay, Suda Tekin, Basak Akyollu, Emre Arpali, Berna Yelken, Munci Kalayoglu, Koçak, Burak (ORCID 0000-0002-0312-2447 & YÖK ID 220671), Arpalı, Emre, Akyollu, Başak, Yelken, Berna, Koruk, Süda Tekin, Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580), Türkmen, Aydın, Kalayoğlu, Münci, and Koç University Hospital
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,medicine.medical_treatment ,Population ,Pneumonia, Viral ,Middle East respiratory syndrome coronavirus ,Coronavirus infections ,Hajj ,030230 surgery ,Asymptomatic ,Article ,03 medical and health sciences ,Betacoronavirus ,Immunocompromised Host ,0302 clinical medicine ,Risk Factors ,MMF, Mycophenolate Mofetil ,Pandemic ,Medicine ,Humans ,Risk factor ,education ,Pandemics ,Kidney transplantation ,Pred, Prednisone ,NLR, Neutrophil-Lymphocyte Ratio ,education.field_of_study ,Transplantation ,business.industry ,SARS-CoV-2 ,COVID-19 ,Immunosuppression ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Tac, Tacrolimus ,Transplant Recipients ,COVID-19, Coronavirus Disease 2019 ,HUS, Hemolytic Uremic Syndrome ,030211 gastroenterology & hepatology ,Female ,Surgery ,Viral disease ,medicine.symptom ,business ,Coronavirus Infections ,Immunosuppressive Agents ,SOT, Solid -Organ Transplant - Abstract
The clinical course of viral infections in patients under immunosuppression can be atypical and/or fatal if not diagnosed and treated appropriately. The coronavirus disease 2019 (COVID-19) may also have an atypical presentation. Contrary to the general opinion, transplant patients may be asymptomatic or oligosymptomatic, which could be a risk factor for underdiagnosis and the dissemination of this viral disease. This study presents the clinical features of 2 oligosymptomatic kidney transplant patients diagnosed with COVID-19. We suggest that new screening algorithms for COVID-19 should be reconsidered for the transplant patient population., NA
- Published
- 2020
- Full Text
- View/download PDF
7. Case report: A kidney transplant patient with mild COVID-19
- Author
-
Basak Akyollu, Berna Yelken, Emre Arpali, Suda Tekin, Burak Kocak, and Aydin Turkmen
- Subjects
Graft Rejection ,Pediatrics ,Case Report and Review of the Literature ,Disease ,030230 surgery ,Severity of Illness Index ,0302 clinical medicine ,Prednisone ,Medicine ,Kidney transplantation ,education.field_of_study ,Mortality rate ,Disease Management ,Lupus Nephritis ,SARS‐Cov‐2 ,Infectious Diseases ,030211 gastroenterology & hepatology ,Female ,Coronavirus Infections ,Immunosuppressive Agents ,medicine.drug ,Adult ,medicine.medical_specialty ,Fever ,Population ,Pneumonia, Viral ,kidney transplantation ,Antiviral Agents ,Tacrolimus ,03 medical and health sciences ,Betacoronavirus ,Immunocompromised Host ,Oseltamivir ,COVID‐19 ,Diabetes mellitus ,Severity of illness ,Humans ,education ,Glucocorticoids ,Pandemics ,Transplantation ,business.industry ,SARS-CoV-2 ,COVID-19 ,medicine.disease ,COVID-19 Drug Treatment ,Cough ,Kidney Failure, Chronic ,business - Abstract
Coronavirus Disease 2019 (COVID‐19) is currently a pandemic with a mortality rate of 1%‐6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID‐19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID‐19. We believe that screening protocols for SARS‐Cov‐2 should be re‐evaluated in patients with solid‐organ transplants.
- Published
- 2020
8. Robotic assisted partial nephrectomy with cold ischemia applying ice pieces and intraoperative frozen section evaluation of the mass: complete replication of open approach with advantages of minimally invasive surgery
- Author
-
Mevlana Derya Balbay, Emre Arpali, Abdullah Erdem Canda, Arif Ozkan, Tarık Esen, Ersin Koseoglu, Murat Can Kiremit, Burak Kocak, and Yakup Kordan
- Subjects
medicine.medical_specialty ,Frozen section procedure ,Robotic assisted ,business.industry ,medicine.medical_treatment ,cold ischemia ,General Medicine ,Video Abstract ,frozen section ,Replication (computing) ,Nephrectomy ,Surgery ,Invasive surgery ,robotic surgery ,medicine ,Renal mass ,Robotic surgery ,renal mass ,Cold ischemia ,business ,robotic partial nephrectomy - Published
- 2020
9. Kidneys with small renal masses: Can they be utilized for kidney transplantation in the era of partial nephrectomy?
- Author
-
Bilal Gunaydin, Turhan Caskurlu, Burak Kocak, Asif Yildirim, Emre Arpali, and Turgay Turan
- Subjects
Transplantation ,medicine.medical_specialty ,Kidney ,business.industry ,medicine.medical_treatment ,Urology ,Hilum (biology) ,Collection system ,medicine.disease ,Nephrectomy ,Metastasis ,medicine.anatomical_structure ,medicine ,Gradual increase ,business ,Kidney transplantation - Abstract
Objective To retrospectively evaluate our database to determine our partial nephrectomy and radical nephrectomy rates and to see percentage of the discarded kidneys which were suitable for transplantation after radical nephrectomy. Material and methods Patients who underwent radical or partial nephrectomy between January 2000 and December 2016 were identified. Only stage I tumors according to tumor, node, metastasis classification were included in this review. Tumor size, location, proximity to renal collecting system and hilum were considered while deciding the suitability of a kidney for transplantation. Results A statistically significant gradual increase in the number of patients treated with partial nephrectomy was observed (p=0.00001). Only 17 out of 181 kidneys with a tumor size smaller than 3 cm could be an appropriate candidate for a renal transplantation if they were to be transplanted. Conclusion Exact number of the discarded kidneys with small renal masses which can be used for kidney transplantation should be determined by large scale studies. A national or governmental policy may only be developed to utilize these discarded organs after the magnitude of the wasted kidneys can be determined.
- Published
- 2018
10. Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantation
- Author
-
Emre Arpali, Robert R. Redfield, Dixon B. Kaufman, Eric J. Martinez, Talal Al-Qaoud, G. Leverson, Hans W. Sollinger, and Jon S. Odorico
- Subjects
Adult ,Graft Rejection ,Male ,medicine.medical_specialty ,030232 urology & nephrology ,Delayed Graft Function ,Constriction, Pathologic ,030230 surgery ,Graft function ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Kidney transplantation ,Male gender ,Retrospective Studies ,Transplantation ,Kidney ,business.industry ,Patient Selection ,Open surgery ,Graft Survival ,Patient survival ,Middle Aged ,Prognosis ,medicine.disease ,Kidney Transplantation ,Surgery ,Survival Rate ,surgical procedures, operative ,medicine.anatomical_structure ,Kidney Failure, Chronic ,Female ,Ureteral Stricture ,Graft survival ,business ,Follow-Up Studies ,Ureteral Obstruction - Abstract
We aimed to evaluate the influence of urological complications occurring within the first year after kidney transplantation on long-term patient and graft outcomes, and sought to examine the impact of the management approach of ureteral strictures on long-term graft function. We collected data on urological complications occurring within the first year posttransplant. Graft survivals, patient survival, and rejection rates were compared between recipients with and without urological complications. Male gender of the recipient, delayed graft function, and donor age were found to be significant risk factors for urological complications after kidney transplantation (P < .05). Death censored graft survival analysis showed that only ureteral strictures had a negative impact on long-term graft survival (P = .0009) compared to other complications. Death censored graft survival was significantly shorter in kidney recipients managed initially with minimally invasive approach when compared to the recipients with no stricture (P = .001). However, graft survival was not statistically different in patients managed initially with open surgery (P = .47). Ureteral strictures following kidney transplantation appear to be strongly negatively correlated with long-term graft survival. Our analysis suggests that kidney recipients with ureteral stricture should be managed initially with open surgery, with better long-term graft survival.
- Published
- 2018
11. Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States
- Author
-
Ryan J. Bennett, David P. Foley, Emre Arpali, Michael E. Anderson, Dixon B. Kaufman, Anthony M. D'Alessandro, Joshua D. Mezrich, Robert R. Redfield, Luis A. Fernandez, Joseph R. Scalea, and Glen Leverson
- Subjects
Adult ,Graft Rejection ,Male ,Organ procurement organization ,Brain Death ,medicine.medical_specialty ,Time Factors ,Tissue and Organ Procurement ,Renal function ,030230 surgery ,Kidney Function Tests ,Time to death ,Donor Selection ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Registries ,Kidney transplantation ,Retrospective Studies ,Transplantation ,Kidney ,business.industry ,Donor selection ,Graft Survival ,Retrospective cohort study ,Middle Aged ,Prognosis ,medicine.disease ,Kidney Transplantation ,Tissue Donors ,United States ,Heart Arrest ,Surgery ,medicine.anatomical_structure ,Kidney Failure, Chronic ,Female ,030211 gastroenterology & hepatology ,Graft survival ,business ,Hospitals, High-Volume ,Follow-Up Studies ,Glomerular Filtration Rate - Abstract
For donation after circulatory death (DCD), many centers allow 1 h after treatment withdrawal to donor death for kidneys. Our center has consistently allowed 2 h. We hypothesized that waiting longer would be associated with worse outcome. A single-center, retrospective analysis of DCD kidneys transplanted between 2008 and 2013 as well as a nationwide survey of organ procurement organization DCD practices were conducted. We identified 296 DCD kidneys, of which 247 (83.4%) were transplanted and 49 (16.6%) were discarded. Of the 247 recipients, 225 (group 1; 91.1%) received kidneys with a time to death (TTD) of 0-1 h; 22 (group 2; 8.9%) received grafts with a TTD of 1-2 h. Five-year patient survival was 88.8% for group 1, and 83.9% for group 2 (p = 0.667); Graft survival was also similar, with 5-year survival of 74.1% for group 1, and 83.9% for group 2 (p = 0.507). The delayed graft function rate was the same in both groups (50.2% vs. 50.0%, p = 0.984). TTD was not predictive of graft failure. Nationally, the average maximum wait-time for DCD kidneys was 77.2 min. By waiting 2 h for DCD kidneys, we performed 9.8% more transplants without worse outcomes. Nationally, this practice would allow for hundreds of additional kidney transplants, annually.
- Published
- 2017
12. Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection - a retrospective study
- Author
-
Arjang Djamali, Emre Arpali, Didier A. Mandelbrot, Brad C. Astor, Sandesh Parajuli, Dixon B. Kaufman, Jon S. Odorico, Fahad Aziz, Robert R. Redfield, and Hans W. Sollinger
- Subjects
Adult ,Graft Rejection ,Male ,Pathology ,medicine.medical_specialty ,Concordance ,Biopsy ,030232 urology & nephrology ,Urology ,Transplants ,030230 surgery ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Humans ,Retrospective Studies ,High rate ,Transplantation ,Kidney ,medicine.diagnostic_test ,business.industry ,Large series ,Retrospective cohort study ,Middle Aged ,Kidney Transplantation ,medicine.anatomical_structure ,Female ,Pancreas Transplantation ,business ,Pancreas ,Biopsy findings - Abstract
It is commonly assumed that in simultaneous pancreas and kidney (SPK) recipients, rejection of the two organs is concordant. As a result, concurrent biopsies of both organs are rarely performed and there are limited histological data on how often rejection is in fact discordant. We reviewed all SPK recipients transplanted at the University of Wisconsin between January 01, 2001, and December 31, 2016, that underwent biopsy of both organs. We included all patients whose biopsies were within 30 days. If patients were treated for rejection between biopsies, they were excluded if the biopsies were more than 4 days apart. Ninety-one simultaneous biopsies were performed within 30 days of each other, and 40 met our inclusion criteria. A total of 25 (62.5%) patients had concordance of biopsy findings: 11 had rejection of both organs, and 14 had no rejection of either organ. The other 15 (37.5%) were discordant for rejection, with 10 having pancreas-only rejection and five kidney-only rejection. It was striking to find that four of the 11 patients with concordance for rejection (36%) had different types (AMR, ACR, or mixed) of rejection in the two organs. This large series of simultaneous pancreas and kidney biopsies demonstrates the continued utility of performing biopsies of both organs.
- Published
- 2017
13. Contents Vol. 81, 2008
- Author
-
Claudio Panzironi, Faruk Gonenc, Daimantas Milonas, Stephen Wyler, Yasuhide Miyoshi, Klaus Kleinschmidt, C. Leonardo, C. Spiliopoulou, C. Van Audenhove, P.M. Braun, Bruno Guastella, Jun Ju, Yoshinobu Kubota, Soroush Rais-Bahrami, Pier-Luigi Degiorgis, K. Haustermans, Consolato Sergi, Wafaa Jamal, A. Alevizou, Hannes Steiner, Kazuhide Makiyama, Claudia Braun, Seung Choul Yang, F. Sofras, Giuseppe Mario Ludovico, Young Deuk Choi, A. Mariolis, K. De Ridder, Richard E. Hautmann, Luigi Cormio, Yi Rong Chen, Michael Mitterberger, Yusuf Ali, BaoGuang Shi, Nam Hoon Cho, Georg Bartsch, M. Soli, S. Junius, Sung Joon Hong, Joo Wan Seo, Mark Schrader, R. Sacco, Josef Oswald, A. Kumar, Wolf H. Weiske, Berkan Resorlu, Ahmed Magheli, Yuan Li, Amit Khandkar, A. Srivastava, Vincent O. Rotimi, J.R. Scheepe, Christian Radmayr, Viktoras Saferis, Elijah O. Kehinde, Takayuki Murakami, Ahmet Yazicioglu, Mesut Gürdal, A. Alevizos, R. Papalia, Apurva Chaudhary, Kadir Türkölmez, Carsten Kempkensteffen, Pritesh Srimali, Bjoern G. Volkmer, Sümer Baltaci, A. Loreto, Takeshi Watanabe, Yaşar Bedük, M. Gallucci, K. Bovis, Muzaffer Eroglu, N. Gupta, K.P. Jünemann, K. Stamatiou, Ege Can Serefoglu, Ikuo Miyagawa, Önder Kayıgil, Rainer Kuefer, Çağatay Göğüş, S. Isebaert, Kang Su Cho, Fathima Khodakhast, Roberto Ponchietti, Sumiyo Toji, Sung Yul Park, R. Coppola, Nesrin Turhan, F.S. Van Rey, Noboru Nakaigawa, P. Alken, Dong Soo Park, D. Desai, Ahmet Metin, S. Guaglianone, A. Athanasopoulos, H. Van Poppel, J.P.F.A. Heesakkers, Christian Gozzi, Mindaugas Jievaltas, Yogesh Bhandari, Jeong Yun Shim, Jürgen Zumbé, Bruno Giammusso, Mert Altinel, Emre Arpali, S. Joniau, Mohammed Seshah, Masahiro Yao, Nicolai Leonhartsberger, Giovanni M. Colpi, J. Simon, E.J. McGuire, Daniel Porres, Stefan Hinz, G. Simone, Ali Fuat Atmaca, Francesco Montorsi, V. Srinivas, Thomas Akkad, and Cemil Yagci
- Subjects
Traditional medicine ,business.industry ,Urology ,Medicine ,business - Published
- 2008
14. Pancreas transplantation in older patients is safe, but patient selection is paramount
- Author
-
Dixon B. Kaufman, Robert R. Redfield, Emre Arpali, Hans W. Sollinger, Glen Leverson, Jon S. Odorico, and Joseph R. Scalea
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,030230 surgery ,Pancreas transplantation ,Diabetes Complications ,03 medical and health sciences ,0302 clinical medicine ,Older patients ,medicine ,Humans ,Pancreatic graft ,Kidney transplantation ,Aged ,Retrospective Studies ,Transplantation ,Kidney ,business.industry ,General surgery ,Patient Selection ,Graft Survival ,Pancreatic Diseases ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Tissue Donors ,Surgery ,Death ,surgical procedures, operative ,medicine.anatomical_structure ,Kidney Failure, Chronic ,030211 gastroenterology & hepatology ,Graft survival ,Female ,Pancreas Transplantation ,business ,Pancreas - Abstract
Pancreas transplant outcomes have progressively improved. Despite this, some centers have continued to employ historical age limits for pancreas transplant candidates. We sought to determine the importance of chronological age in determining patient and graft survival rates after pancreas transplantation. A single-center, retrospective study of adult, deceased donor simultaneous pancreas and kidney (SPK) and solitary pancreas transplants (SP, including pancreas transplant alone and pancreas after kidney transplants) in recipients ≥ 55 years (55 + ), occurring between July 1, 1999, and June 30, 2012, was performed. Seven-hundred and forty patients underwent pancreas transplantation, of which 28 patients were 55 + . Patient survival was comparable for younger and older pancreas transplant recipients. Both non-death-censored and death-censored pancreatic graft survival rates were similar in younger and in older patients. Patients aged 45-54 and those aged 55 + had more frequent cardiovascular events than younger pancreas transplant recipients. There was no difference in renal graft survival for SPK patients when compared with diabetic kidney transplant alone recipients aged 55 years and older. Older pancreas transplant recipients had acceptable long-term patient and graft survival rates, although complications may occur. Chronological age alone should not exclude a patient for pancreas transplant candidacy.
- Published
- 2015
15. The efficacy of radiographic anatomical measurement methods in predicting success after extracorporeal shockwave lithotripsy for lower pole kidney stones
- Author
-
Semih Yasar Sargin, Mert Altinel, and Emre Arpali
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Urology ,Radiography ,medicine.medical_treatment ,Urographies ,Lithotripsy ,lcsh:RC870-923 ,Kidney ,Sensitivity and Specificity ,Calculi ,Extracorporeal shockwave lithotripsy ,Kidney Calculi ,Reference Values ,medicine ,Humans ,Measurement method ,business.industry ,Lower pole ,Reproducibility of Results ,lcsh:Diseases of the genitourinary system. Urology ,medicine.disease ,Anatomical measurement ,Surgery ,Treatment Outcome ,Kidney stones ,Female ,Radiology ,business - Abstract
Objectives To assess the impact of lower pole calyceal anatomy on clearace of lower pole stones after extracorporeal shockwave lithotripsy (ESWL) by means of a new and previously defined radiographic measurement method. Materials and Methods Sixty-four patients with solitary radiopaque lower pole kidney stones were enrolled in the study. Infundibulopelvic angle (IPA), infundibulotransverse angle (ITA), infundibular lenght(IL), and infundibular width (IW) were measured on the intravenous urographies which were taken before the procedure. Results 48 of 64 patients (75%) were stone-free after a follow-up period of 3 months. The IPA,ITA,IL and IW were determined as statistically significant factors, while age,gender and stone area were found to have no impact on clearance. Conclusion By the help of radiographic measurement methods related to lower pole kidney anatomy, appropriate patient selection and increment in success after ESWL may be achieved.
- Published
- 2014
16. Subject Index Vol. 81, 2008
- Author
-
C. Van Audenhove, P.M. Braun, Jun Ju, Pier-Luigi Degiorgis, K. Haustermans, Mohammed Seshah, Kazuhide Makiyama, Masahiro Yao, Nicolai Leonhartsberger, Giovanni M. Colpi, J. Simon, E.J. McGuire, Viktoras Saferis, Elijah O. Kehinde, N. Gupta, Ali Fuat Atmaca, Takayuki Murakami, Yoshinobu Kubota, F. Sofras, Amit Khandkar, Hannes Steiner, Joo Wan Seo, Sung Joon Hong, K. De Ridder, A. Srivastava, J.P.F.A. Heesakkers, Claudio Panzironi, A. Alevizou, Faruk Gonenc, Christian Gozzi, Dong Soo Park, V. Srinivas, Ahmet Metin, Yuan Li, Yi Rong Chen, S. Isebaert, Thomas Akkad, Mesut Gürdal, Luigi Cormio, D. Desai, Nesrin Turhan, Josef Oswald, A. Kumar, Yusuf Ali, BaoGuang Shi, S. Guaglianone, Wolf H. Weiske, Stephen Wyler, Daimantas Milonas, Yasuhide Miyoshi, J.R. Scheepe, H. Van Poppel, Cemil Yagci, S. Junius, Mindaugas Jievaltas, A. Mariolis, Wafaa Jamal, Nam Hoon Cho, A. Alevizos, Önder Kayıgil, A. Athanasopoulos, Noboru Nakaigawa, C. Spiliopoulou, Bruno Guastella, Sümer Baltaci, A. Loreto, Bjoern G. Volkmer, Takeshi Watanabe, Ahmed Magheli, Roberto Ponchietti, Soroush Rais-Bahrami, Yogesh Bhandari, Michael Mitterberger, Sumiyo Toji, Rainer Kuefer, Jürgen Zumbé, Kang Su Cho, Francesco Montorsi, Giuseppe Mario Ludovico, M. Soli, Richard E. Hautmann, Sung Yul Park, Daniel Porres, Çağatay Göğüş, Stefan Hinz, Fathima Khodakhast, K. Bovis, R. Sacco, Vincent O. Rotimi, Jeong Yun Shim, M. Gallucci, G. Simone, Ahmet Yazicioglu, R. Coppola, S. Joniau, Bruno Giammusso, R. Papalia, Apurva Chaudhary, Kadir Türkölmez, F.S. Van Rey, Klaus Kleinschmidt, Mert Altinel, P. Alken, C. Leonardo, Muzaffer Eroglu, K.P. Jünemann, Emre Arpali, Mark Schrader, Georg Bartsch, Yaşar Bedük, Claudia Braun, Seung Choul Yang, Young Deuk Choi, K. Stamatiou, Berkan Resorlu, Christian Radmayr, Carsten Kempkensteffen, Pritesh Srimali, Ege Can Serefoglu, Ikuo Miyagawa, and Consolato Sergi
- Subjects
medicine.medical_specialty ,Index (economics) ,business.industry ,Urology ,General surgery ,medicine ,Subject (documents) ,business - Published
- 2008
17. CONCISE REVIEW: β CELL REPLACEMENT THERAPIES IN TREATMENT OF DIABETES MELLITUS
- Author
-
Umay Çelik, Özge Sezin Somuncu, Büşra Ergün, and Emre Arpalı
- Subjects
stem cell therapy ,islet cells ,pancreas ,Science (General) ,Q1-390 - Abstract
Metabolic rate of glucose uptake is generally controlled by a feedback mechanism covering islet β cells and insulin-sensitive tissues, wherein tissue sensitivity to insulin influences the level of β-cell comeback. In case of insulin presence, β cells preserve standard glucose tolerance via enhancing insulin production. Even though β-cell dysfunction has a strong hereditary component, environmental alterations carry an important part as well. Current research methods have facilitated to establish the important part of hexoses, amino acids, and fatty acids in the development of insulin resistance and β-cell dysfunction, therefore more operative treatments to slow the progressive loss of β-cell function are required. Latest discoveries from clinical research deliver significant information about approaches to stop and treat diabetes and some of the adversative properties of these interferences. Generation of satisfactory numbers of pancreatic endocrine cells that work in the same way as primary islets is of supreme prominence for the expansion of cell treatments to cure. In this study, we focused on different techniques starting from islet and pancreas transplantations individually and ending on new therapies such as stem cell technology and bioengineering. We aimed to establish a comprehensive and detailed explanation of treatment perspectives for islet cell loss. This review is carrying a novel potential for enlightening the current treatments and future-based therapies.
- Published
- 2019
- Full Text
- View/download PDF
18. Acknowledgement to the Reviewers
- Author
-
Viktoras Saferis, Elijah O. Kehinde, Francesco Montorsi, Takayuki Murakami, Amit Khandkar, M. Gallucci, A. Srivastava, Daniel Porres, Muzaffer Eroglu, Stefan Hinz, Nesrin Turhan, Giuseppe Ludovico, C. Van Audenhove, P.M. Braun, G. Simone, Georg Bartsch, Luigi Cormio, Wolf H. Weiske, J.P.F.A. Heesakkers, Jun Ju, Yoshinobu Kubota, Christian Gozzi, Önder Kayıgil, Dong Soo Park, Takeshi Watanabe, Çağatay Göğüş, J.R. Scheepe, Berkan Resorlu, D. Desai, Nam Hoon Cho, Christian Radmayr, C. Leonardo, Noboru Nakaigawa, K. Haustermans, A. Alevizos, Ali Fuat Atmaca, K. Bovis, S. Junius, Mindaugas Jievaltas, Daimantas Milonas, Claudia Braun, Ahmet Metin, Seung Choul Yang, Bruno Giammusso, Mohammed Seshah, Mert Altinel, Young Deuk Choi, R. Coppola, Yi Rong Chen, Ahmed Magheli, Joo Wan Seo, Roberto Ponchietti, F.S. Van Rey, Emre Arpali, Mark Schrader, K. De Ridder, S. Guaglianone, Masahiro Yao, H. Van Poppel, Nicolai Leonhartsberger, Giovanni M. Colpi, E.J. McGuire, V. Srinivas, R. Papalia, P. Alken, A. Athanasopoulos, Yusuf Ali, BaoGuang Shi, Thomas Akkad, Kang Su Cho, Yogesh Bhandari, Wafaa Jamal, Carsten Kempkensteffen, Claudio Panzironi, Faruk Gonenc, Pier-Luigi Degiorgis, Cemil Yagci, Fathima Khodakhast, Kazuhide Makiyama, Jeong Yun Shim, S. Joniau, Pritesh Srimali, Yuan Li, Sumiyo Toji, Klaus Kleinschmidt, F. Sofras, Mesut Gürdal, Sung Yul Park, Rainer Kuefer, Yasuhide Miyoshi, Yaşar Bedük, Ege Can Serefoglu, Ikuo Miyagawa, Soroush Rais-Bahrami, N. Gupta, Hannes Steiner, Jürgen Zumbé, Richard E. Hautmann, S. Isebaert, Consolato Sergi, C. Spiliopoulou, Bruno Guastella, Bjoern G. Volkmer, K. Stamatiou, Josef Oswald, A. Kumar, Sümer Baltaci, A. Loreto, Michael Mitterberger, M. Soli, R. Sacco, Stephen Wyler, K.P. Jünemann, Sung Joon Hong, Vincent O. Rotimi, Ahmet Yazicioglu, Apurva Chaudhary, Kadir Türkölmez, A. Mariolis, A. Alevizou, and Joerg Simon
- Subjects
Medical education ,business.industry ,Urology ,Acknowledgement ,Medicine ,business - Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.